Clinical trials of chimeric antigen receptor (CAR)-modified T cells have shown promise in hematologic malignancies. However, in solid tumors, the clinical responses have been less impressive. It is important to determine how to further improve the clinical effects of CAR-modified T cells. In this review, we focus on recent clinical trials and analyze the factors that determine clinical responses, including the following: 1) the composition of the CAR; 2) the preparation of CAR-modified T Cells; 3) the clinical treatment schedule; 4) the patient characteristics. We also propose future Strategies that must be investigated before the technology can be used in a wider range of clinical applications.
Related Content
Modes of Delivery of Genetic Testing Services and the Uptake of Cancer Risk Management Strategies in BRCA1 and BRCA2 Carriers
Modes of Delivery of Genetic Testing Services and the Uptake of Cancer Risk Management Strategies in BRCA1 and BRCA2 Carriers


Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women’s Healthcare Practitioners
Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women’s Healthcare Practitioners
Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growth
Microsporidian genome analysis reveals evolutionary strategies for obligate intracellular growth


Damselflies use different movement strategies for short- and long-distance dispersal
Damselflies use different movement strategies for short- and long-distance dispersal
Colour Polymorphism and Alternative Breeding Strategies: Effects of Parent’s Colour Morph on Fitness Traits in the Common Wall Lizard
Colour Polymorphism and Alternative Breeding Strategies: Effects of Parent’s Colour Morph on Fitness Traits in the Common Wall Lizard

Integrated joint pest management strategies in the presence of control spillovers
Integrated joint pest management strategies in the presence of control spillovers
Strategies for Outcrossing and Genetic Manipulation of Drosophila Compound Autosome Stocks
Strategies for Outcrossing and Genetic Manipulation of Drosophila Compound Autosome Stocks

Comparison of similarity-based tests and pooling strategies for rare variants
Comparison of similarity-based tests and pooling strategies for rare variants
Next-generation phenotyping: requirements and strategies for enhancing our understanding of genotype–phenotype relationships and its relevance to crop improvement
Next-generation phenotyping: requirements and strategies for enhancing our understanding of genotype–phenotype relationships and its relevance to crop improvement

Luminescent and colorimetric strategies for the label-free DNA-based detection of enzyme activity
Luminescent and colorimetric strategies for the label-free DNA-based detection of enzyme activity